UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Tesco is the UK’s biggest grocer again — and its FY26 results explain exactly why Aldi and Lidl should be paying attention
Read More Pharma Industry News FDA approves Italfarmaco’s Duvyzat for duchenne muscular dystrophy treatment In a significant advancement for the treatment of Duchenne muscular dystrophy (DMD), Italfarmaco S.p.A. has announced the U.S.… byPallavi MadhirajuMarch 24, 2024